Topical antibiotics: Strategies for avoiding ototoxicity

Ear, Nose and Throat Journal

Volumn 83, Issue 1 SUPPL., 2004, Pages 12-14

  Haynes, David S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLOTRIMAZOLE; DEXAMETHASONE; EAR DROPS; MICONAZOLE; NYSTATIN; OFLOXACIN; TOLNAFTATE;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; DRUG SAFETY; HUMAN; MENIERE DISEASE; NEPHROTOXICITY; OTITIS MEDIA; OTOTOXICITY;

EID: 1642541100     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130408301s04     Document Type: Conference Paper

References (24)

1. Schatz A, Bugie E, Waxman SA. Streptomycin, a substance exhibiting antibiotic activity against gram positive and gram negative bacteria. Proc Soc Exp Biol Med 1944;55:66-9.
2. Morizono T, Johnstone BM. Ototoxicity of topically applied gentamicin using a statistical analysis of electrophysiological measurement. Acta Otolaryngol 1975;80:389-93.
3. Barlow DW, Duckert LG, Kreig CS, Gates GA. Ototoxicity of topical otomicrobial agents. Acta Otolaryngol 1995;115:231-5.
4. Russell PT, Church CA, Jinn TH, et al. Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells. Acta Otolaryngol 2001;121:135-9.
5. Lundy LB, Graham MD. Ototoxicity and ototopical medications: A survey of otolaryngologists. Am J Otol 1993;14:141-6.
6. Roland PS. Clinical ototoxicity of topical antibiotic drops. Otolaryngol Head Neck Surg 1994;110:598-602.
7. Helal A. Aminoglycoside ear drops and ototoxicity. CMAJ 1997;156:1056-8.
8. Wooltorton E. Ototoxic effects from gentamicin ear drops. CMAJ 2002;167:56.
9. Bath AP, Walsh RM, Bance ML, Rutka JA. Ototoxicity of topical gentamicin preparations. Laryngoscope 1999;109:1088-93.
10. Longridge NS. Topical gentamicin vestibular toxicity. J Otolaryngol 1994;23:444-6.
11. Canadian Adverse Reaction Newsletter 2001;11:7-8.
12. Schuknecht HF. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol 1957;132(Suppl):1-42.
13. Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000;110:236-40.
14. Kaplan DM, Hehar SS, Bance ML, Rutka JA. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: Further evidence for topical eardrop ototoxicity. Laryngoscope 2002;112:689-95.
15. Aursnes J. Vestibular damage from chlorhexidine in guinea pigs. Acta Otolaryngol 1981;92:89-100.
16. Spandow O, Anniko M, Moller AR. The round window as access route for agents injurious to the inner ear. Am J Otolaryngol 1988;9:327-35.
17. Morizono T. Toxicity of ototopical drugs: Animal modeling. Ann Otol Rhinol Laryngol Suppl 1990;148:42-5.
18. Tom LW. Ototoxicity of common topical antimycotic preparations. Laryngoscope 2000;110:509-16.
19. Force RW, Hart MC, Plummer SA, et al. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg 1995;121:880-4.
20. Tutkun A, Ozagar A, Koc A, et al. Treatment of chronic ear disease. Topical ciprofloxacin vs topical gentamicin. Arch Otolaryngol Head Neck Surg 1995;121:1414-16.
21. Esposito S, Noviello S, D'Errico G, Montanaro C. Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg 1992;118:842-4.
22. Yuen AP, Chau PY, Wei WI. Bacteriology of chronic suppurative otitis media: Ofloxacin susceptibility. J Otolaryngol 1995;24:206-8.
23. Goldblatt EL. Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes. Pediatr Infect Dis J 2001;20:116-19.
24. Fischel-Ghodsian N, Prezant TR, Bu X, Oztas S. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am J Otolaryngol 1993;14:399-403.